Large group of adults and children posing and wearing sunglasses.

let's recode what's possible



  • March 29, 2019: We Receive Positive CHMP Opinion
    bluebird bio receives positive opinion from CHMP recommending conditional marketing authorization for our investigational treatment for patients with transfusion dependent β-thalassemia

  • A group of bluebird bio employees participating in a celebratory ribbon cutting ceremony in front of a building

    March 21, 2019: bRT Ribbon Cutting
    Our nest in North Carolina is open for business!

  • Inhibrix's Company Logo

    January 7, 2019: We Announce A Partnership With Inhibrix
    bluebird bio announces exclusive license agreement to research, develop and commercialize chimeric antigen receptor (CAR) T cell therapies using Inhibrx’s proprietary single domain antibody (sdAb) platform to multiple cancer targets.


  • Illustration of a heart and an infusion bag

    October 5, 2018: Our Regulatory Application Is Accepted By The EMA
    bluebird bio announces European Medicines Agency’s Acceptance of Marketing Authorization Application of our investigational treatment for patients with transfusion-dependent β-thalassemia.

  • Gritstone's Company Logo

    August 23, 2018: We Announce Partnership With Gritstone Oncology, Inc.
    bluebird bio announces a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.

  • Regeneron's Company Logo

    August 6, 2018: Strategic Collaboration With Regeneron Announced
    bluebird bio announces collaboration with Regeneron to discover, develop and commercialize new cell therapies for cancer

  • Picture of a mother and father seated on either side of their son with cerebral adrenoleukodystrophy

    May 23, 2018: FDA Grants Us Breakthrough Therapy Designation In ALD
    bluebird's investigational gene therapy for cerebral ALD was granted Breakthrough Therapy designation by the U.S. FDA.

  • America’s Got Talent contestant, Mandy Harvey, in the bluebird bio offices with a plush bird stuffed animal on her head

    May 20, 2018: Our First Superstar Day
    Each bird is allowed to invite 1-2 people that inspire them to visit the office and to see what we do here on behalf of patients. Our speaker and performer for year one was America’s Got Talent contestant, Mandy Harvey.


  • TCBiopharma's Company Logo

    December 7, 2017: Strategic Collaboration With TC Biopharma Announced
    Collaboration with TC Biopharma announced to research and develop Gamma Delta CAR T cell product candidates for cancer immunotherapy

  • Whiteboard with handwritten welcome message and bird drawings

    March 21, 2017: We Move To The Newest Nest!
    Our Facilities team celebrates after receiving the Certificate of Occupancy for our new nest at 60 Binney, Cambridge MA.


  • Apceth's Company Logo

    December 15, 2016: We Enter Into A Partnership With Apceth Biopharma
    Our manufacturing relationship with Apceth provides us with European commercial manufacturing capabilities

  • Medigene's Company Logo

    September 29, 2016: R&D Collaboration With Medigene Announced
    bluebird  bio announces strategic research and development collaboration and licensing agreement with Medigene AG for T cell receptor (TCR) immunotherapies against four targets.

  • Illustration of red blood cells

    September 21, 2016: We Receive PRIME Designation By The EMA
    Our investigational treatment for patient with transfusion-dependent β-thalassemia was given PRIME designation by European Medicines Agency (EMA)

  • Lonza's Company Logo

    June 9, 2016: We Enter Into A Strategic Agreement With Lonza
    bluebird bio announces strategic manufacturing agreement with Lonza Houston, Inc., providing for future commercial production of our drug products

  • bluebird bio's first European employee sitting in a chair holding a sign that says 'make your mark'

    June 6, 2016: Our First EU Bird Joins The Nest
    Gabriella joined the nest as our first hire in Italy. We now have EU birds in Switzerland, Italy, France, the Netherlands, and the UK too!

  • Pediatric patient walking down the bluebird bio hallway high-fiving employees lined up on either side

    April 29, 2016: Daron's bluebird Day
    bluebird invites Daron, a 12 year old boy fighting cancer, to be our Chief Scientific Officer for the day! All birds fly with Daron!

  • February 17, 2016: First Multiple Myeloma Patient Treated
    First patient treated with bb2121 anti-BCMA CAR T cell therapy in Phase 1 study in patients with relapsed/refractory multiple myeloma.


  • October 14, 2014: First Sickle Cell Disease Patient Treated
    The first patient treated in a clinical study of our investigational treatment for sickle cell disease was a milestone for bbb and patients.

  • March 3, 2014: First Transfusion-Dependent β-thalassemia Patient Treated
    The first patient treated in a clinical study of our investigational treatment for β-thalassemia was a milestone for bbb and patients.


  • Exterior photograph of the building at 150 Second Street in Cambridge Massachusetts

    December 29, 2013: We Move to 150 Second Street in Cambridge
    As bluebird continues to grow, the team moves to their new nest at 150 Second Street in Cambridge.

  • Members of the Ethan Zakes Foundation holding two of Ethan's skateboards

    September 18, 2013: First Ever bbb Auction!
    The all-employee auction has become an annual bluebird tradition. Each year, employees donate and bid on items to raise money for the charity of our choosing including the Ethan Zakes Foundation, Brian’s Hope, Sickle Cell Community Consortium, Thalassemia Support Foundation and most recently in 2018 for Stupid Cancer.

  • Pregenen's Company Logo

    June 30, 2013: We Acquire Pregenen
    bluebird expands to the West Coast by acquiring some kick-ass birds with a unique gene editing platform. We now have a nest in Seattle, WA.

  • Group photograph of all bluebird employees present on the day of the company's IPO

    June 19, 2013: $BLUE Goes Public
    bluebird's initial public offering (IPO)

  • Celgene's Company Logo

    March 15, 2013: Collaboration with Celgene Announced
    bluebird collaborates with Celgene to discover, develop and commercialize novel, disease-altering gene therapies in oncology.


  • Group photograph of bluebird bio employees participating in BioBall

    April 28, 2012: First Participation in BioBall
    BioBall is a one day basketball tournament that partners with the Mass Bio-Tech community to raise money for Special Olympics Massachusetts. - BioBall is now an annual tradition for bluebird.


  • bluebird bio's CEO Nick Leschley pictured with Phil Reilly, bluebird bio's first Chief Medical Officer at the company's first ever offsite

    September 9, 2010: Founding Day of bluebird bio
    Genetix becomes bluebird


  • Genetix's original company logo

    April 16, 1992: Genetix Founded